On September 25, the research team led by Shen Zhongyang and Wang Shusen from Tianjin First Central Hospital, together with Deng Hongkui's team from Peking University/Changping Laboratory, published a landmark paper in the top journal Cell. For the first time globally, they achieved clinical functional cure of type 1 diabetes through innovative stem cell-derived islet transplantation. The patient no longer required exogenous insulin therapy during the 1-year follow-up period.